Stay updated on Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.2 to v3.6.3, indicating a new site version.
    Difference
    0.1%
    Check dated 2026-07-05T13:17:33.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page's revision history shows a new version (v3.6.2), indicating a small metadata update to the study record.
    Difference
    0.1%
    Check dated 2026-06-28T06:27:09.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    New guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note indicates recruitment is closed. A heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment' to align with other sections.
    Difference
    0.4%
    Check dated 2026-06-14T06:50:32.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing the previous v3.5.4. This indicates a minor release of the page or underlying system rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-06-07T03:25:13.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The revision tag in the page footer was updated from v3.5.3 to v3.5.4, reflecting a new build of the page. This change is metadata-only and does not modify the study details or displayed content.
    Difference
    0.1%
    Check dated 2026-05-16T10:29:57.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page footer release/version indicator advanced from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-25T06:15:18.000Z thumbnail image

Stay in the know with updates to Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page.